. 2020 Aug 25;7:555. doi: 10.3389/fvets.2020.00555

Table 5.

DEXA body composition by obesification group and time point (study week) during weight loss.

Group	Baseline	1 week	4 weeks	8 weeks	12 weeks¹
Fat mass (kg)
ObN	7.1 ± 0.5^b^,^#	6.7 ± 0.5^b^,^#	5.9 ± 0.6^b^,^c^,^#^,^$	4.9 ± 0.7^b^,^c^,^$^,^%	4.0 ± 1.0^b^,^%
ObP	6.7 ± 1.0^b^,^#	6.3 ± 0.7^b^,^#	6.3 ± 0.7^c^,^#	5.8 ± 0.7^c^,^#	5.7 ± 0.8^c^,^#
WLD	6.4 ± 1.4^b^,^#	5.9 ± 1.4^b^,^#^,^$	4.9 ± 1.1^b^,^$^,^%	3.7 ± 0.9^a^,^b^,^$^,^%^,^∧	3.1 ± 0.8^a^,^∧
IBW	2.1 ± 0.5^a^,^#	2.2 ± 0.4^a^,^#	2.8 ± 0.4^a^,^#^,^$	3.0 ± 0.4^a^,^$	2.8 ± 0.3^a^,^#^,^$
Body fat (%)
ObN	42.9 ± 2.9^b^,^#	42.9 ± 3.0^b^,^#	39.5 ± 2.5^c^,^#^,^$	35.6 ± 2.9^b^,^$^,^%	30.8 ± 5.4^b^,^%
ObP	38.7 ± 3.6^b^,^#	37.3 ± 3.5^b^,^#	38.0 ± 3.5^b^,^c^,^#	36.3 ± 4.0^b^,^#	36.0 ± 4.9^b^,^#
WLD	38.8 ± 5.3^b^,^#	37.5 ± 6.1^b^,^#^,^$	33.6 ± 5.8^b^,^$	27.1 ± 6.3^a^,^%	24.0 ± 4.6^a^,^%
IBW	18.7 ± 4.0^a^,^#	19.4 ± 3.0^a^,^#	23.1 ± 2.7^a^,^#^,^$	25.3 ± 2.5^a^,^$	23.7 ± 2.2^a^,^#^,^$
Lean mass (kg)
ObN	9.0 ± 0.6^a^,^b^,^#	8.5 ± 0.7^a^,^#	8.5 ± 0.6^a^,^#	8.4 ± 0.9^a^,^#	8.4 ± 0.7^a^,^#
ObP	10.1 ± 0.9^c^,^#	10.0 ± 1.1^b^,^#	9.8 ± 0.7^b^,^#	9.8 ± 0.8^b^,^#	9.7 ± 0.8^c^,^#
WLD	9.6 ± 0.4^b^,^c^,^#	9.2 ± 0.2^a^,^b^,^#	9.1 ± 0.2^a^,^b^,^#	9.2 ± 0.4^b^,^#	9.1 ± 0.2^b^,^c^,^#
IBW	8.6 ± 0.8^a^,^#	8.7 ± 0.6^a^,^#	8.7 ± 0.6^a^,^#	8.6 ± 0.6^a^,^#	8.6 ± 0.5^a^,^b^,^#
Lean (%)
ObN	54.4 ± 2.9^a^,^#	54.3 ± 3.0^a^,^#	57.4 ± 2.5^a^,^#^,^$	61.1 ± 2.8^a^,^$^,^%	65.7 ± 5.1^a^,^%
ObP	58.6 ± 3.4^a^,^#	59.7 ± 3.5^a^,^#	59.1 ± 3.4^a^,^b^,^#	60.7 ± 4.0^a^,^#	60.9 ± 4.9^a^,^#
WLD	58.5 ± 5.0^a^,^#	59.6 ± 5.8^a^,^#	63.3 ± 5.6^b^,^#^,^$	69.2 ± 5.8^b^,^$^,^%	72.6 ± 4.6^b^,^%
IBW	77.6 ± 4.0^b^,^#	76.9 ± 2.9^b^,^#	73.4 ± 2.8^c^,^#^,^$	71.3 ± 2.5^b^,^$	72.7 ± 2.3^b^,^#^,^$
DEXA total mass (kg)
ObN	16.5 ± 0.6^b^,^#	15.7 ± 0.7^b^,^#^,^$	14.9 ± 1.0^b^,^$^,^%	13.7 ± 1.4^b^,^%^,^∧	12.8 ± 1.4^b^,^∧
ObP	17.2 ± 1.5^b^,^#	16.8 ± 1.2^b^,^#	16.6 ± 0.8^c^,^#	16.1 ± 0.6^c^,^#	15.9 ± 0.5^c^,^#
WLD	16.5 ± 1.5^b^,^#	15.6 ± 1.4^b^,^#^,^$	14.5 ± 1.0^b^,^$^,^%	13.3 ± 0.8^b^,^%^,^∧	12.6 ± 1.0^a^,^b^,^∧
IBW	11.1 ± 0.8^a^,^#	11.3 ± 0.7^a^,^#	11.9 ± 0.7^a^,^#	12.0 ± 0.7^a^,^#	11.8 ± 0.7^a^,^#

Numerical data presented as mean ± standard deviation.

^*ObN, obese nutraceutical group; ObP, obese placebo group; WLD, weight loss diet group; IBW, ideal body weight group.

Except where otherwise indicated, n = 5 for obesification groups (ObN, ObP, WLD) and n = 6 for group IBW.

WLD in this column determined from 4 dogs, because 1 dog reached ideal weight and ended treatment at 8 weeks.

^a,b,c

Within a column, values with different superscript letters differ significantly (p < 0.05).

^#,$,%,∧

Across columns, values with different superscript symbols differ significantly (p < 0.05).